Market Overview:
The global allergic rhinitis treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergic rhinitis, increasing awareness about allergic rhinitis and its treatment, and technological advancements in the field of allergy diagnosis and treatment. However, the high cost of therapies is expected to restrain the growth of this market during the forecast period. The global allergic rhinitis treatment market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into antihistamines, intranasal corticosteroids (INCS), immunotherapies (allergy shots), decongestants, and others (including saline nasal sprays). On the basis of application, it can be classified into seasonal allergic rhinitis and perennial allergic rhinitis. Geographically speaking, it is analyzed across North America (the U.S., Canada), Latin America (Mexico & Brazil), Europe (Germany France Italy Spain UK) Asia Pacific excluding Japan) Japan Middle East & Africa).
Product Definition:
Allergic rhinitis is a common condition that results when the body's immune system reacts to inhaled particles, such as pollen, dust, or pet dander. Allergic rhinitis can cause sneezing, itching, and watery eyes. It can also lead to a stuffy nose and congestion.
Antihistamines:
Antihistamines are used for the treatment of allergic rhinitis. Allergic rhinitis is a type of chronic, inflammatory condition of the nose and nasal passages that causes symptoms such as sneezing, itching, congestion, and watery eyes. The most common cause of allergic rhinitis is exposure to dust or vapor from certain plants (allergens), especially trees or grasses that contain latex.
Intranasal Corticosteroids:
Intranasal corticosteroids are the medications that are used for the treatment of allergic rhinitis. The drug works by decreasing nasal congestion and inflammation in the nose. Corticosteroid drugs can be administered as a spray, drop or pill and they are more effective when they are used at the first sign of an attack.
Application Insights:
The seasonal allergic rhinitis segment dominated the global application market in 2017. The segment is expected to witness significant growth over the forecast period owing to its high prevalence among people of all ages and both genders. According to a study, published in Allergy, Asthma & Sinusitis journal, around 40% of patients suffering from allergies have been reported to experience some type of nasal congestion during allergy season.
Perennial allergic rhinitis is also a major concern as it affects more than just one season and persists for longer than usual without any relief. It has been estimated that around 15% - 20% population across the globe suffers from perennial allergic rhinitis at any given time and need medical attention only when their symptoms last for more than 10 days or if they become severe enough to impact their daily activities or studies.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing awareness about various treatment options, high disposable income, and availability of effective branded drugs. Moreover, growing prevalence of allergic disorders coupled with rising adoption of innovative therapeutics is also expected to drive growth in this region.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare infrastructure and rising demand for allergen-free products among consumers especially in India & China and other Southeast Asian countries such as Indonesia & Malaysia etc., which are emerging hubs for pharmaceutical manufacturing facilities due to low labor costs involved there compared with developed regions such as North America & Europe etc.
Growth Factors:
- Increasing prevalence of allergic rhinitis
- Growing awareness about allergic rhinitis and its treatment options
- Rising demand for allergen-free products
- Technological advancements in allergy diagnosis and treatment methods
- Growing number of research studies on allergic rhinitis
Scope Of The Report
Report Attributes
Report Details
Report Title
Allergic Rhinitis Treatment Market Research Report
By Type
Antihistamines, Intranasal Corticosteroids, Immunotherapies, Decongestants, Others
By Application
Seasonal Allergic Rhinitis, Perenial Allergic Rhinitis
By Companies
Merck, Johnson & Johnson, Sanofi, GlaxoSmithKline, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Allergic Rhinitis Treatment Market Report Segments:
The global Allergic Rhinitis Treatment market is segmented on the basis of:
Types
Antihistamines, Intranasal Corticosteroids, Immunotherapies, Decongestants, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Seasonal Allergic Rhinitis, Perenial Allergic Rhinitis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Johnson & Johnson
- Sanofi
- GlaxoSmithKline
- Novartis
Highlights of The Allergic Rhinitis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antihistamines
- Intranasal Corticosteroids
- Immunotherapies
- Decongestants
- Others
- By Application:
- Seasonal Allergic Rhinitis
- Perenial Allergic Rhinitis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Allergic Rhinitis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Allergic rhinitis is a condition in which the nose becomes inflamed and itchy because of an allergic response to something. Treatment typically includes medications, nasal sprays, or eye drops.
Some of the key players operating in the allergic rhinitis treatment market are Merck, Johnson & Johnson, Sanofi, GlaxoSmithKline, Novartis.
The allergic rhinitis treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Allergic Rhinitis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Allergic Rhinitis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Allergic Rhinitis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Allergic Rhinitis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Allergic Rhinitis Treatment Market Size & Forecast, 2018-2028
4.5.1 Allergic Rhinitis Treatment Market Size and Y-o-Y Growth
4.5.2 Allergic Rhinitis Treatment Market Absolute $ Opportunity
Chapter 5 Global Allergic Rhinitis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Allergic Rhinitis Treatment Market Size Forecast by Type
5.2.1 Antihistamines
5.2.2 Intranasal Corticosteroids
5.2.3 Immunotherapies
5.2.4 Decongestants
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Allergic Rhinitis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Allergic Rhinitis Treatment Market Size Forecast by Applications
6.2.1 Seasonal Allergic Rhinitis
6.2.2 Perenial Allergic Rhinitis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Allergic Rhinitis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Allergic Rhinitis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Allergic Rhinitis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Allergic Rhinitis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Allergic Rhinitis Treatment Market Size Forecast by Type
9.6.1 Antihistamines
9.6.2 Intranasal Corticosteroids
9.6.3 Immunotherapies
9.6.4 Decongestants
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Allergic Rhinitis Treatment Market Size Forecast by Applications
9.10.1 Seasonal Allergic Rhinitis
9.10.2 Perenial Allergic Rhinitis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Allergic Rhinitis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Allergic Rhinitis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Allergic Rhinitis Treatment Market Size Forecast by Type
10.6.1 Antihistamines
10.6.2 Intranasal Corticosteroids
10.6.3 Immunotherapies
10.6.4 Decongestants
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Allergic Rhinitis Treatment Market Size Forecast by Applications
10.10.1 Seasonal Allergic Rhinitis
10.10.2 Perenial Allergic Rhinitis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Allergic Rhinitis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Allergic Rhinitis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Allergic Rhinitis Treatment Market Size Forecast by Type
11.6.1 Antihistamines
11.6.2 Intranasal Corticosteroids
11.6.3 Immunotherapies
11.6.4 Decongestants
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Allergic Rhinitis Treatment Market Size Forecast by Applications
11.10.1 Seasonal Allergic Rhinitis
11.10.2 Perenial Allergic Rhinitis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Allergic Rhinitis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Allergic Rhinitis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Allergic Rhinitis Treatment Market Size Forecast by Type
12.6.1 Antihistamines
12.6.2 Intranasal Corticosteroids
12.6.3 Immunotherapies
12.6.4 Decongestants
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Allergic Rhinitis Treatment Market Size Forecast by Applications
12.10.1 Seasonal Allergic Rhinitis
12.10.2 Perenial Allergic Rhinitis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Allergic Rhinitis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Allergic Rhinitis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Allergic Rhinitis Treatment Market Size Forecast by Type
13.6.1 Antihistamines
13.6.2 Intranasal Corticosteroids
13.6.3 Immunotherapies
13.6.4 Decongestants
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Allergic Rhinitis Treatment Market Size Forecast by Applications
13.10.1 Seasonal Allergic Rhinitis
13.10.2 Perenial Allergic Rhinitis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Allergic Rhinitis Treatment Market: Competitive Dashboard
14.2 Global Allergic Rhinitis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Johnson & Johnson
14.3.3 Sanofi
14.3.4 GlaxoSmithKline
14.3.5 Novartis
